02 Oct 2018
Biologique Recherche launches new face cream informed by DNA research
BY Lauren Heath-Jones
Luxury French skincare brand Biologique Recherche has launched La Grande Créme, a new face cream that is designed to target epigenetic ageing, caused by non-genetic factors including lifestyle.
It is formulated with EpigenActiv, a unique peptide that can counteract the effects of ageing and reverse DNA damage.
Discovered in Biologique Recherche’s Gene Expression Laboratory, EpigenActiv acts on the epidermal growth factor (EGF) receptors in the skin, to aid the reparation of damaged tissues and promote cellular regeneration.
Rupert Schmid, co-owner and co-CEO of Biologique Recherche, says: "Each individual’s genetic heritage expresses itself differently over the course of a lifetime and one’s lifestyle.
"We’ve conducted numerous studies in order to repair negative traits within cells and counter cutaneous ageing and develop even better anti-ageing skin care products. La Grande Crème is a complete cream that contains the greatest number of concentrated active ingredients ever used in a Biologique Recherche product and, for the first time ever, DNA research has made it possible to identify and use the properties of EpigenActiv© in an anti-ageing skincare product.”
In addition to EpigenActiv, the cream contains milk thistle and mimosa extracts to revive the skin, peony extract to restructure, extracts of elderflower, chestnut tree and myrobalan leaf to firm, and a complex of Matrikines, Myorelaxant peptides and Carcinine to reduce the appearance of wrinkles.
Other active ingredients include: extracts of white tea and watercress spout and soy-based pure Genistein to prevent blemishes, and Oligosaccharides and extracts of Anomala, Wasabi and grape juice to protect the skin.
Close Window